Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients-Reference-Cited by-同舟云学术

Microarray-based analysis of the BRAF V600 mutations in circulating tumor DNA in melanoma patients

Published:2021-01 Issue: Volume:250-251 Page:25-35
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Emelyanova Marina A.^ORCID,Telysheva Ekaterina N.,Orlova Kristina V.^ORCID,Ryabaya Oxana O.^ORCID,Snigiryova Galina P.,Abramov Ivan S.,Mikhailovich Vladimir M.^ORCID

Funder

Russian Science Foundation

Ministry of Science and Higher Education of the Russian Federation

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference54 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. New strategies in melanoma: molecular testing in advanced disease;Woodman;Clin Cancer Res,2012

3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

4. Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials;Lovly;PLoS One,2012

5. Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032;Rubinstein;J Transl Med,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasensitive detection of genetic variation based on dual signal amplification assisted by isothermal amplification and cobalt oxyhydroxide nanosheets/quantum dots;Microchimica Acta;2023-12-08

2. Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review;Journal of Pharmaceutical Analysis;2023-12

3. Biological Microarray for Detection of Somatic Mutations in the Genes of Isocitrate Dehydrogenase 1 and 2;Биоорганическая химия;2023-09-01

4. Biological Microarray for Detection of Somatic Mutations in the Genes of Isocitrate Dehydrogenase 1 and 2;Russian Journal of Bioorganic Chemistry;2023-08-21

5. Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives;Current Treatment Options in Oncology;2022-03-17